In human NASH liver biopsies with increased TRIM21 expression, we also measured decreased SREBP1, FASN, and ACC proteins levels, which were accompanied by unchanged steady-state mRNA levels (Supplemental Figure 2K and Supplemental Figure 5F). This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatohepatitis.